Upload
pinay-yaun
View
159
Download
0
Tags:
Embed Size (px)
Citation preview
Bloodlines
Above: From pluripotent cells arise the WBC and RBC and lymphoid series. Note that some cells will arise from the same mother cell.
Anemias Reduction below normal limits of the total
circulating red cell mass Reduced oxygen transport capacity of the
blood Reduction below normal in the volume of
packed red cell as measured by hematocrit or hemoglobin concentration
IOW, the patient will appear pale and weak from lack of oxygen.
Classification of Anemia According to Underlying Mechanism
Blood loss Increased rate of destruction (hemolytic
anemias) Impaired red cell production
Anemia of Blood Loss
Acute blood loss (microcytic, hypochromatic RBC’s may not be evident)
Reflect loss of blood volumemay lead to shock, death
Hemodilutionshift of water from interstitial fluid compartment into intravascular space
Erythropoietin productionreticulocytosis (Immature RBC containing remnants of nuclei seen only in special stain. Bigger than usual RBC. Polychromatophilicbluish – red hue) reaching 10 – 15%
Reticulocyte count normally 0.5 – 1.5%Chronic blood loss (microcytic, hypochromic RBC’s are more evident in chronic blood loss)
GIT bleeding: gastric ulcer, hematemesis, hemorrhoidso Striking reticulocytosis may not be seen.
Gynecologic causes
Subject: PathologyTopic: RBC’s and Bleeding DisordersLecturer: Dr. CagampanDate of Lecture: August 9, 2011Transcriptionist: Mopster and Pinay Editor: Mopster and Pinay
Increased Rate of Destruction (Hemolytic Anemia) Intrinsic (intracorpuscular) abnormalities of
red cellso Hereditary
Red cell membrane disorders Disorders of membrane
cytoskeleton: spherocytosis, elliptocytosis
Disorders of lipid synthesis: selective increase in membrane lecithin
Red cell enzme deficiencies Glycolytic enzymes: pyruvate
kinase deficiency, hexokinase deficiency
Enzymes of hexose monophosphate shunt: G6PD, glutathione synthetase
Disorders of hemoglobin synthesis Deficient globin synthesis:
thalassemia syndromes Structurally abnormal globin
synthesis (hemoglobinopathies): sickle cell anemia, unstable hemoglobin
o Acquired Membrane defect: paroxysmal
nocturnal hemoglobinuria Extrinsic (extracorpuscular) abnormalities
o Antibody mediated Isohemagglutinins: transfusion
reactions, erythroblastosis fetalis Autoantibodies: idiopathic
(primary), drug associated, SLE, malignant neoplasm, mycoplasmal infections
o Mechanical trauma to red cells Microangiopathic hemolytic
anemia: thrombotic thrombocytopenic purpura, DIC
Cardiac traumatic hemolytic anemia Infections: malaria Chemical injury: lead poisoning Sequestration in mononuclear
phagocyte system: hypersplenism
Impaired Red Cell Production Disturbance of proliferation and
differentiation of stem cells: aplastic anemia, pure red cell aplasia, anemia of renal failure, anemia of endocrine disorders
Disturbance of proliferation and maturation of erythroblasts:o Defective DNA synthesis: deficiency or
impaired use of vitamin B12 and folic acid (megaloblastic anemia)
o Defective hemoglobin synthesis Deficient heme synthesis: iron
deficiency Deficient globin synthesis:
thalassemias
Unknown or multiple mechanisms: sideroblastic anemia, anemia of chronic infections, myelophthisic anemia due to marrow infiltration
Hemolytic Anemia Premature destruction of red cells and a
shortened red cell life span below the normal 120 days
Elevated erythropoietin levels and a compensatory increase in erythropoiesis
Markedly increased erythropoiesis with associated reticulocytosis
Accumulation of hemoglobin degradation products released by red cell breakdown derived from hemoglobin (e.g., bilirubin)
Pigment stone formation as a result of hemoglobin degradation.
Tend to produce extravascular hemolysis although, on occasion, intravascular hemolysis may occur.
Tend to be autosomal dominant Rare in the Philippines, except Thalassemia. Intravascular hemolysis (causes):
o Mechanical injury: e.g., prosthetic cardiac valves, thrombi
o Complement fixation to red cells: e.g., mismatched transfusion
o Toxic injury: e.g., malaria
Manifestations of intravascular hemolysis :o Anemiao Hemoglobinemiao Hemoglobinuriao Jaundice: a small percentage of gall
stones are of hemoglobin origino Hemosiderinuria
Extravascular hemolysis o Occurs in mononuclear phagocytes of
spleen o Predisposing factors:
Red blood cell membrane injury Reduced deformability opsonization
o Sequestration of “deformed” or “foreign” red blood cells followed by opsonization phagocytosis as red cells navigate sinusoids
o These sequestered RBC’s are rendered “palatable” to macrophages due to hypoxia and ATP depletion.
o Clinical features Anemia Splenomegaly Jaundice
Morphology of hemolytic anemias o Normoblastic hyperplasia in marrowo Reticulocytosis in peripheral bloodo Pigment gallstoneso Hemosiderosiso Jaundice, anemia
Below: Defective RBC’s sequestered outside are then phagocytized.
Hereditary Spherocytosis Intrinsic defect in RBC membraneankyrin
deficiency and other (usually spectrin) skeletal membrane components
RBCspheroidal, less deformable, vulnerable to splenic sequestration and destruction
Ankyrin deficiencyassociated with reduced stability and loss of membrane fragments as cells traverse circulation
Inherited disorder, in Northern Europe Autosomal dominant Morphology:
o Spheroidal RBC (normal is biconcave disc)
o No central pallor notedo Moderate splenomegaly due to marked
congestion of the cords of Billrotho Erythrophagocytes in the splenic cords o Features of hemolytic anemia
Clinical course: treatment is splenomegalyo Chronic hemolytic anemia mild to
moderateo Aplastic crisis parvovirus infectiono Hemolytic crisiso Diagnosis: Osmotic Fragility Test
Below: Cell membrane defect leads to formation of spherocytes, which are sequestered and rendered palatable to macrophages.
Below: How primary membrane defect leads to phagocytosis on a chemical basis. This pathophysiology is common to most hemolytic anemia and needs to be known by heart.
Below (next 2 photos): Note round shape of RBC’s and absence of central pallor.
G6PD Deficiency X – linked One of the tests for newborn screening Impaired or deficient enzyme function
which reduce ability of red cells to fight against oxidative injuries
Abnormalities in Hexose Monophosphate Shunt pathway or glutathione metabolism
Need reduced glutathione to protect RBC against oxidants
Primary
membrane skelet
al defect
Surface to volume ratio
(spherocytosis) Cellular deformity
Membrane instability
Membrane loss
ATP depletionAcid-induceddamage
Macrophageprocessing
Erythrostasis Glucose pH Macrophage contactHemolysis
?phagocytosis?osmotic lysis
???
PATHOPHYSIOLOGY OF HEREDITARY SPHEROCYTOSIS
PATHOPHYSIOLOGY OF HEREDITARY SPHEROCYTOSIS
Oxidant stress:o Drugs: antimalarials, sulfonamides, etco Infection: viral hepatitis, TF, pneumoniao Fava bean ingestion
Pathogenesis: Oxidative stress results in the oxidation of globin chains which causes the globin chains to denature and precipitate to form Heinz Bodies. Heinz bodies render the RBC palatable to phagocytes. Sometimes, the Heinz bodies are so abundant, that intravascular hemolysis can occur. Extravascular and intravascular hemolysis can occur.
Below: Not the Bite Cell in the center of the larger picture. In the smaller picture in the upper left corner, note the presence of Heinz Bodies under special stain.
Sickle Cell Anemia Structurally abnormal hemoglobin Substitution of valine for glutamic acid at
the 6th position of β globin chain American blacks:
o Heterozygote: 40% HgbSo Homozygote: 100% HgbS
Under deoxygenation, the RBC will sickle. At first the sickling is reversible until such
time that the RBC can no longer change its shape and is sequestered and phagocytized.
Infarction: sickle cells have the unique feature of having increased adhesion to each other. This what causes them to aggregate and form thrombi which can lead to infarct.
Morphology:o Hyperplastic marrowlead to
resorption of boneo Extramedullary hematopoiesis
o Sickle red cellso Initial splenomegaly erythrocytosis
thrombosis and infarction scarring autosplenectomy
o Infarction in bone, brain, kidney, liver, and retina
o Leg ulcer, cor pulmonaleo Pigment gallstones
Clinical course:o Severe anemia: reticulocytosiso Vasoocclusive complications: acute
chest syndromeo Chronic hyperbilirubinemia: gallstoneso Increased susceptibility to
infectionsepticemia and meningitiso CNS hypoxia: seizures, strokeo Aplastic crisis: triggered by parvovirus
infectiono Sequestration crisiso Priapism: thrombi lead congestion of
blood vessels which can lead to persistent, painful erection.
Diagnosiso PBS, metabisulfite-induced sicklingo Hemoglobin electrophoresiso Fetal DNA by chorionic biopsy of
amniocentesisBelow: Single point mutation leads to sickle cell formation which leads to hemolysis in the spleen and infract in the tissues.
Below: Sickle cell admixed with anisocytosis, hypochromia, poikylocytosis
Below: Spleen shrunken down to 3 cm.
Below: Severe congestion because of trapping of the RBC’s
Thalassemia α type seen in the Philippines
o There are 2 genetic loci for the α chain, thus there are 4 alleles. There are 4 types of α thalassemia, each type coinciding to a loss a allele. Type 1: Loss or mutation of single
allele. Minimal symptomatology because the other 3 chains are present.
Type 2: 2 alleles affected. Mild anemia.
Type 3: 3 alleles affected. Leads to Hemoglobin H.
Type 4: 4 alleles affected. Hydrops fetalis. No chance of survival.
Patients with mild forms of the disease are usually asymptomatic and are noticed to have anemia when a CBC is ordered. They are then given iron, which does not improve the anemia. The astute doctor may suspect another diagnosis, order an electrophoresis and this is when thalassemia is diagnosed.
Mendelian disorder characterized by a lack of or decreased synthesis of either α or β globin chain of HbA
β Thalassemialack of β globin chains with excess α chaino Thalassemia major: both alleles of the
β chain are affected.o Thalassemia minor: only one allele of
the β chain is affected. Aka, Cooley’s anemia.
α Thalassemialack of α globin chains, with excess β, γ, δ
Excess chains will precipitate and result in phagocytosis
Facie: prominent cheekbones because of increased blood production
Target cells: typical cells seen in Thalassemia but not exclusive to it.
Morphology: same as in all HAo “Crew-cut” appearance of bone on X-
ray due to marrow expansion with thinning of cortical bone with few bone formation on the external aspect
o Hepatosplenomegalyo Hemosiderosis
Clinical course:o Growth retardationo Death at early age of homozygous
patiento Manifestation depends on severityo Prone to infection
Below: Typical facie of patient with thalassemia. Prominent cheekbones are a result of increased blood production by the facial bones in order to compensate for RBC loss.
Below: Pathophysiology of β thalassemia. There is reduced β hemoglobin with a relative excess α hemoglobin as a compensatory mechanism. The excess α globin precipitates in RBC. Most die in bone marrow, but some will make it into circulation where they will be sequestered in spleen and destroyed. The resulting anemia causes increased erythropoiesis and increased iron absorption as the body attempts to correct the anemia. As a result, bone marrow expansion occurs as does systemic iron overload. The bone deformities that result in the facie are a result of bone marrow expansion. Note that iron overload also comes from destruction of the erythroblasts within the bone marrow and from regular blood transfusions that are required by these patients.
Below (next 3 pics): Target cells. Note: these are not exclusive to thalassemias.
Below: “Crew cut” appearance of skull resulting from increased erythropoiesis.
Below: Hepatic hemosiderosis in Beta Thalassemia
Assignment: Another name for target cell, why does it happen?Answer: Codocyte, leptocyte, or Mexican hat cell. Seen in thalassemia, liver disease, post – splenectomy patient. What causes targeting is uneven distribution of hemoglobin.
Paroxysmal Nocturnal Hemoglobinuria Acquired defect in cell membrane Somatic mutation of the PIGA gene which is
essential for synthesis of the GPI (glycophosphatidylinositol) anchor
GPI – linked proteinsinactivate complement
Other cells affected because GPI is found in all blood cells, so patient can have pancytopenia.
If patient is subject to an immune reaction involving complement it can lead to lysis.
Ham’s Test: how it’s diagnosed.
Immunohemolytic Anemia Demonstration of the anti – RBC Ab Coomb’s Test
Classification of Immune Hemolytic Anemias Warm Antibody Type
o The antibody is of the IgG type, does not usually fix complement and is active at 37° C.
o Primary (Idiopathic)o Secondary
Lymphomas and leukemias Other neoplastic diseases Autoimmune disorders (particularly
SLE) Drugs
Cold Agglutinin Type o The antibodies are IgM and are most
active in vitro at 0° C to 4° C. Antibodies dissociate at 30° or above; agglutination of cells by IgM and complement fixation only in peripheral cool parts of the body (eg, ears, toes, and fingers)
o Acute: Mycoplasmal infection Infectious Mononucleosis
o Chronic: Idiopathic Associated with lymphoma
Cold Hemolysin type (Paroxysmal Hemoglobinuria)o IgG antibodies bind red cells at cold
temperature, fix complement, and cause hemolysis when the temperature is raised above 30° C.
Hemolytic Anemia Resulting from Trauma to rBC1. Prosthetic cardiac valves (mechanical)2. Microangiopathic Hemolytic Anemia:
abnormally narrowed vesselsa. In DIC, malignant HTN, SLE, TTP,
Hemolytic-uremic syndrome, disseminated cancer
b. See schistocytes, burr, helmet cells, and triangle cells (couldn’t find a pic, but some explanations basically say these are RBC remnants that resemble triangles). Note: schistocytes are usually a sign of trauma, intravascular or extravascular.
Below: Schistocyte
Below: Burr cell
Below: Target cell
Below: Helmet cell. Resembles Bite Cell, but Bite Cell will have 1 bite, Helmet Cell will have >1 bite.
Anemias of Diminished Erythropoiesis
Megaloblastic Anemia Impaired DNA synthesis leading to defective
nuclear maturation. DNA synthesis is affected but RNA synthesis does not.
Asynchronism between nuclear and cytoplasmic maturation. Immature nucleus with very mature and often huge cytoplasm
Due to folate or vitamin B12 deficiency. o Vitamin B12 must be obtained through
the diet. It is absorbed in the ileum and requires intrinsic factor.
o These are necessary for DNA synthesiso RNA synthesis continueso There is a lag so cell becomes
megaloblastic Morphology:
o Macro – ovalocyteso Hypersegmented neutrophils (>6 lobes)o Bone marrow hypercellular (1:1)o Megakaryocytes large with bizarre,
multilobate nucleio Ineffective
erythropoiesisintramedullary destruction of megaloblast
o Increased hemolytic destruction of RBCo Leukopenia and thrombocytopeniao In short, pancytopenia
Below: Normal vitamin B12 metabolism. R – binder is produced by the salivary gland. Vitamin B12 is digested in the stomach via gastric acids and binds with R – binder. It is carried through the small intestine, where the B12 – R-binder complex is digested by proteases. Vitamin B12 is now bound to Intrinsic Factor and carried to the ileum, where it is absorbed into the portal circulation. Intrinsic factor is the switch by which vitamin B12 is absorbed. Disruption of the GI tract, loss of R – binder or Intrinsic Factor can all lead to malabsorpton of vitamin B12.
Below: Macroovalyctes. Bone marrow would be hypercellular, composed of RBC series, all megaloblasts. Because megaloblastic anemia affects all cell lines, PMN’s will also be affected. They will appear, as below, as hypersegmented (>5 lobes) because of the asynchrony between DNA and RNA synthesis. Sometimes, the deficiency is so bad, RBC’s can be destroyed in the bone marrowineffective erythropoiesis just like Thalassemia. Again, megaloblastic anemia may manifest as pancytopenia in the bone marrow.
Below: Bone marrow looks busy, hypercellular. The cells are very large nucle, hyperchromatic, and granular. There appears to be maturation of the cytoplasm with a lag in the nucleus:cytoplasm ratio.
Below (next 3 pictures): Macro – ovalocytes in the PBS with schistocytes.
Pernicious Anemia Autoimmune destruction of gastric mucosa Chronic atrophic gastritis lack of intrinsic
factor Presence of autoantibodies against parietal
cellsblocking Ab, Type II Ab and parietal canalicular Ab
Morphology:o GIT
Atrophic glossitis Diffuse chronic gastritis. This is
specific to pernicious anemia. If it is not due to pernicious anemia, you won’t find this.
Intestinalization of gastric glandso CNS lesion
Myelin degeneration of the dorsal and lateral tractssensory motor deficits
Diagnostic features:o Moderate to severe megaloblastic
anemiao Leucopenia with hypersegmented
granulocyteso Mild to moderate thrombocytopeniao Neurologic changes: “subacute
combined degeneration”o Achlorydia even after histamine
stimulation. Remember, histamine is supposed to release gastric acids. The patient with pernicious anemia will not do this.
o Inability to absorb oral dose of cobalamine – “Schilling Test”
o Low serum B12o Excretion of methylmalonic acid in urineo Improvement after parenteral B12o Demonstration of antibody to instrinsic
factor
Below: Atrophic glossitis
Below: Atrophic gastritis
Below: myelin degeneration of the dorsal tracts
Below: Myelin degeneration of the lateral tracts
Folate Deficiency Same as B12 deficiency but without
neurologic changes
Iron Deficiency Anemia Most common nutritional deficiency Iron is absorbed in the duodenum and can
be recycled. Storage pool of Fe: hemosiderin and
ferritin Ferritin:
o Protein – iron complex; stored in parenchymal cells or within RES
o Level is a good indicator of adequacy of body iron stores
o Iron deficiency anemia↓iron↓Ferritin
Transferrin:o Iron – binding glycoprotein which
transports iron in plasma; deliver iron to cells including erythroid precursors (TIBC)
o When iron is deficient↑TIBC (because the body is scavenging for iron)
Causes of iron deficiency:o Dietary lack: in elderly, poor, infants,
and childreno Impaired absorption: in malabsorptiono Increased requirement: growing infants
and children, adolescents, premenopausal, pregnancy
Anemias of Diminishe
d Erythropoi
esis
PERNICIOUS ANEMIAMorphology:
GIT atrophic glossitis diffuse chronic gastritis - atrophy of
fundic glands affecting chief and parietal cells
intestinalization of gastric glands- goblet cells
CNS lesion
myelin degeneration of dorsal and lateral tracts
o Chronic blood loss: hemorrhoids, GIT Ca, parasitism, menstrual abnormalities, urinary tract bleeding
Morphology:o Normoblastic hyperplasia in marrowo Microcytic, hypochromic RBC
Diagnosis:o PBS findings, decreased hemoglobin
and hematocrit, low serum Fe and serum Ferritin TIBC (transferrin concentration) is high
Below: Microcytic, hypochromic RBC’ssmall and paler central pallor. The PMN is used as a point of reference to determine the relative size of RBC. PMN’s are around 12μm. The RBC’s in the PBS below are ¼ the size, so around 4 – 5 μm. Normal RBC’s are usually 6 – 7 μm, or 1/3 the size of a PMN.
Anemia of Chronic Disease Reduced erythroid proliferation and
impaired Fe utilization Chronic infection: osteomyelitis, bacterial
endocarditis, lung abscess Chronic immune disorder: RA, Crohn’s Neoplasms: Hodgkin’s CA of lung and
breast Pt. peripheral blood smear may appear like
iron deficiency anemia, but stores are normal
The failure is in the utilization of iron, not in the amount.
Diagnosis:o Low serum Fe, decreased TIBC but
abundant stored iron in marrow macrophage
o Low erythropoietin levels marrow hypoproliferation
Aplastic Anemia Pancytopenia characterized by anemia,
neutropenia, and thrombocytopenia Bone marrow is almost converted to fat.
Cells present are usually lymphocytes. Normal BM is 50:50.
Morphology:o Markedly hypocellular marrow – “fatty
marrow”o Fibrous tissue with scattered
lymphocytes
Below: Most of the time cause is unknown, but when it is known, it is usually drug induced.
Below: Pancytopeniaall cells are decreased. Markedly hypocellular marrow. Sometimes fibrotic with scattered lymphocytes.
Below: Note the abundance of fat in the marrow.
Other Forms of Marrow Failure Myelophthisic anemia
o Due to space – occupying lesions in marrow; metastatic carcinoma; multiple myeloma, leukemia, Tb
Diffuse liver disease Chronic renal failure
Below: myelophthisic anemia secondary to leukemia. Leukemias typically fill up the marrow with abnormal cells.
Bleeding Disorders
Can be caused by :o Increased blood vessel fragility/ Vessel
wall abnormalityo Platelet disorders/ abnormality (both in
function and in number)o Coagulation defects
Evaluation requires laboratory testing:o Bleeding time: tests platelet functiono Platelet countso Prothrombin time: tests extrinsic
pathway (Mnemonic: PeT, prothrombin extrinsic time)
o Partial Thromboplastin time: tests intrinsic pathway (Remember: PiTT, partial intrinsic thromboplastin time)
o Specialized tests (e.g., clotting factor levels)
I. Vessel Wall Abnormality relatively common but usually do not
cause serious bleeding typically induce only petechial and
purpuric hemorrhages Can be caused by infections, drug
reactions, autoimmune diseases, vitamin deficiency, immune complex deposits, or hereditary disorders
normal platelet count, BT, PT, and PTT
Conditions which causes increased vascular fragility:1. Infections
a. Meningococcemia (Waterhouse – Friedrichsen syndrome), gram (-) septicemia, infective endocarditis, rickettsiosis
b. Microbiologic damage to vessels (vasculitis) or DIC (Disseminated intravascular coagulation) underlying mechanism
2. Drug reactions – often secondary to immune complex deposition in vessel walls with resulting hypersensitivity vasculitis
3. Poor vascular support
a. Abnormal collagen synthesis (Scurvy, Ehlers- Danlos Syndrome: impaired collagenous support
b. Loss of perivascular supporting tissue (Cushing syndrome)
c. Vascular wall amyloid deposition4. Henoch– Schonlein Purpura: systemic
hypersensitivity reaction of unknown cause characterized by purpuric rash, abdominal pain, polyarthralgia, and acute glomerulonephritis. Associated with vascular and glomerular mesangial deposition of immune complexes.
5. Hereditary hemorrhagic telangiectasia
II. Reduced platelet number: Thrombocytopenia= characterized principally by petechial bleeding, most often from small vessels of skin and mucous membranes. Count is <100,000/mm3
Normal: 150,000 – 450,000/mm3
Thrombocytopenia: <100,000/mm3
Spontaneous bleeding: <20,000/mm3
***Sometimes patient has <10,000/mm3 and patients don’t bleed, or has <50,000/ mm3 and already experienced spontaneous bleeding therefore clinically it really depends on when to start your management; as physicians we should know when to act
Causes:a. Decreased production: due to ineffective
megakaryopoiesis (e.g., megaloblastic states) or to generalized marrow disease that also compromises megakaryocyte number (e.g., aplastic anemia, disseminated cancer).
b. Decreased survival: due to immune-mediated platelet destruction, usually with a compensatory megakaryocytic marrow hyperplasia
-it can follow drug exposure or infections-platelet deficiencies due to consumption often occur in systemic coagulopathies (DIC, hemolytic uremic syndrome, thrombotic thrombocytopenia purpura).
c. Sequestration: platelets are retained in the red pulp of enlarged spleens
d. Dilution: massive whole blood transfusions can cause a relative reduction in the number of circulating platelets because storage for longer than 24 hours at 4°C results in rapid hepatic platelet sequestration upon infusion.
e. HIV: results from immune complex injury, antiplatelet antibodies, and HIV- induced suppression of megakaryocytes.
Idiopathic Thrombocytopenic Purpura (ITP)/ Immune Thrombocytopenic Purpura : antibody- mediated platelet destruction
Acute (children) o Self-limitingo Seen most often in children after a viral
infection (e.g., rubella, cytomegalovirus infection, viral hepatitis, infectious mononucleosis)
o Platelet destruction is due to transient antiplatelet autoantibodies.
Chronic (adult<40 y/o), mostly female of childbearing ageo Long history of easy bruising or
nosebleedso Platelet autoantibodies (synthesized in
the spleen) are usually directed toward one of two platelet antigens (platelet membrane glycoprotein complexes IIb/ IIIa or Ib/IX).
o Destruction of antibody-coated platelets occurs in the spleen.
o Splenectomy benefits 75- 80% of patients
Antiplatelet antibodies Pathogenesis: opsonized platelet
susceptible to phagocytosis by RES cells (in spleen)
Morphology: spleennormal in sizeo Congestion of sinusoids and enlarged
follicleso Prominent germinal centerso Megakaryocytes within sinusoidso Bone marrowincrease number of
megakaryocytes
Below: Bone marrow in ITPincreased number of megakaryocytes, because it is a compensatory mechanism. If ITP count is not increased in the bone marrow, you can pretty much rule out ITP.
Below: normal spleen. But there may be megakaryocytes in the spleen.
Thrombotic Microangiopathies:-characterized by
o Thrombocytopeniao Microangiopathic hemolytic anemiao Fevero Transient neurologic deficits (in TTP)o Renal failure (HUS)
-most of the clinical manifestations are due to widespread hyaline microthrombi in arterioles and capillaries (microcirculation) composed of dense aggregates of platelets and fibrin-platelets adhere more to the thrombi
Thrombotic Thrombocytopenic Purpura (TTP)o Associated with inherited or acquired
deficiencies in ADAMTS13 (a matalloprotease that limits the size of von Willebrand factor multimers in the plasma.
o In adult femaleo Pentad of: fever, thrombocytopenia,
microangiopathic hemolytic anemia, neurologic defects, renal failure
o Probably viral - induced Hemolytic – uremic syndrome (HUS)
o Commonly follows gastrointestinal infections with verotoxin-producing E.coli.
Verotoxin injures endothelial cells promotes dysregulated platelet activationaggregation
o Microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure
o Onset in childhoodo Follow infection with verotoxin –
producing E. coli
Both show widespread formation of hyaline thrombi in microcirculation
Bleeding Related to Defective Platelet FunctionA. Congenital Disorders
1. Defective adhesion a. “Bernard – Soulier Syndrome”:
caused by deficient platelet membrane glycoprotein complex GpIb/ IX- platelet receptor for vWF and necessary for platelet-collagen adhesion
b. Inherited deficiency of platelet membrane glycoprotein
2. Defective aggregation a. Thrombasthenia: caused by
deficient platelet membrane glycoprotein GpIIb/ IIIa- involved in binding fibrinogen
3. Defective secretion- platelet will secrete an enzyme to stabilize the plug
B. Acquired disorders1. Aspirin ingestion- potent inhibitor of
cyclooxygenase and can suppress the synthesis of thromboxane A2 – for platelet aggregation
2. Uremia
III. Bleeding due to Abnormalities in Clotting Factors
von Willebrand’s Disease Autosomal dominant Characterized by spontaneous bleeding
from mucous membranes; excessive bleeding from wounds, menorrhagia
Prolonged BT, PTT, normal platelet count, reduced vWF and Factor VIII levels
May have quantitative or qualitative effect in VWF
Compound defects involving platelet function and coagulation pathway
Hemophilia A (Factor VIII Deficiency) X – linked recessive trait; in male and
homozygous female Reduction in amount or activity of Factor
VIII Severity depends on Factor VIII activity;<1%
Factor VIII activity is severe disease Easy bruising and massive hemorrhage after
trauma or operation Spontaneous joint hemorrhages –
hemarthrosesrecurrent bleedingdeformities
Normal BT, platelet count, and PT, prolonged PTT
Below: Easy bruising is common
Below: Bleeding gums is common
Below: Genogram showing the X – linked inheritance of Hemophilia in the royal families of Europe.
Disseminated Intravascular Coagulation (DIC)-an important complication= not a disease but a complication of some other disease
Acute, subacute, and chronic thrombohemorrhagic disorder occurring as a secondary complication in a variety of disease
Characterized by activation of the coagulation sequence that leads to formation of microthrombi throughout the microcirculation
Consumption of platelets, fibrin, coagulation factors with secondary activation of fibrinolytic mechanisms”Consumptive Coagulopathy”
2 major mechanisms which trigger DICo Release of tissue factors or
thromboplastic substanceso Injury to endothelial cells releasing
thromboplastic substances, which causes:
Massive thrombosis Bleeding to death
***massive thrombosis release of thromboplastic substancestrigger the coagulation system consume more factorsbleed spontaneously death.***Can be difficult to treat as there are 2 stages: thrombotic and bleeding. If patient is in the thrombotic stage, then giving fibrinogen can potentially worsen the condition because it consumes more factors to be used. If during the bleeding stage, giving thrombotic agents can also hasten the bleeding.***Thrombi can lead to ischemia tissue damage
Morphology: o Multiple thrombi in one or several
organso ARDS in lungs, microinfarcts in brain,
adrenal hemorrhages
Below: common causes of DIC. Most common infective agent is Gram negative sepsis. Whatever, the cause, it triggers DIC through the release of coagulation factors.
Below: Pathophysiology of DIC
Below: DIC causes thrombi that can lead to occlusion of the blood vesselsischemia in various organs.
Note: With DIC the patient is usually admitted for another condition, but develops clotting disorders because DIC is a complication and rarely a primary disorder itself.
-------------------------------------------------- End of Transcription --------------------------------------------------------
“And God showed His love for us by sending His own Son into the world.” 1 John 4:9-10